Guardian Pharmacy Services, Inc. (NYSE:GRDN) Stock Has Consensus Target Price of $45.57 According to Analysts

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) have earned an average rating of “Moderate Buy” from the ten analysts that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $45.57.

A number of analysts have issued reports on the stock. KeyCorp started coverage on shares of Guardian Pharmacy Services in a report on Tuesday, September 22nd. They issued an “overweight” rating and a $52.00 price target on the stock. Wall Street Zen downgraded shares of Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a report on Saturday, September 19th. Oppenheimer raised their price objective on Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a research report on Friday, August 7th. Weiss Ratings raised Guardian Pharmacy Services from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. Finally, Truist Financial boosted their target price on Guardian Pharmacy Services from $47.00 to $51.00 and gave the stock a “buy” rating in a research report on Monday, September 21st.

Hedge Funds Weigh In On Guardian Pharmacy Services

Several hedge funds have recently added to or reduced their stakes in the company. State of Alaska Department of Revenue raised its holdings in shares of Guardian Pharmacy Services by 105.9% in the third quarter. State of Alaska Department of Revenue now owns 2,390 shares of the company’s stock worth $97,000 after buying an additional 1,229 shares during the period. Elevation Point Wealth Partners LLC purchased a new position in Guardian Pharmacy Services during the 1st quarter valued at $253,000. Stephens Inc. AR purchased a new position in Guardian Pharmacy Services during the 1st quarter valued at $282,000. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in Guardian Pharmacy Services during the 2nd quarter valued at $335,000. Finally, Arizona State Retirement System grew its position in Guardian Pharmacy Services by 53.0% in the 2nd quarter. Arizona State Retirement System now owns 8,393 shares of the company’s stock valued at $351,000 after acquiring an additional 2,907 shares during the last quarter.

Guardian Pharmacy Services Trading Down 2.2%

NYSE:GRDN opened at $39.69 on Friday. Guardian Pharmacy Services has a 12-month low of $23.72 and a 12-month high of $48.33. The stock has a 50-day moving average price of $40.91 and a 200 day moving average price of $39.87. The stock has a market capitalization of $1.98 billion, a P/E ratio of 38.54, a P/E/G ratio of 2.12 and a beta of 0.03.

Guardian Pharmacy Services (NYSE:GRDN) last released its earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.26 by $0.03. The firm had revenue of $351.77 million for the quarter, compared to the consensus estimate of $340.45 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. On average, research analysts predict that Guardian Pharmacy Services will post 1.18 earnings per share for the current fiscal year.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc (NYSE: GRDN) is a healthcare services company that provides pharmacy services to residents of long-term care and other institutional healthcare settings. Its customers include assisted living communities, skilled nursing facilities, behavioral health centers and communities serving individuals with developmental disabilities.

The company’s services include prescription dispensing, medication packaging and delivery, medication management, pharmacy consulting and clinical support.